Seattle Genetics Inc financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$6.70M $9.76M $10.01M $22.42M $35.24M $51.97M $107.47M $94.78M $210.81M $269.26M $286.76M $336.80M $418.15M $482.25M $654.70M $916.71M $2.18B $1.57B $1.96B $0.00M $0.00M
GM % Gross Margin %
0.00% -255.47% 0.00% 100.00% -214.86% -129.27% -36.23% -75.69% 12.83% 10.95% 9.40% 1.43% -0.83% -5.92% 0.17% 16.73% 51.97% 2.17% 10.60% 0.00% 0.00%
OM Operating Margin
0.00% 0.00% 0.00% -248.19% -260.49% -163.30% -63.46% -152.35% -27.16% -23.35% -26.98% -35.91% -34.13% -40.60% -38.41% -24.06% 27.43% -43.32% -31.24% 0.00% 0.00%
EPS Earnings Per Share
$-0.70 $-0.74 $-0.80 $-1.09 $-0.90 $-0.66 $-1.34 $-0.46 $-0.51 $-0.62 $-0.93 $-1.00 $-0.88 $-1.41 $-1.33 $3.26 $-3.70 $-3.30 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 -0.00% 0 -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% 0.00% -0.00% -0.00% 0 0
Sha. Shares
41.95m 42.38m 51.03m 67.36m 79.78m 100.53m 101.38m 115.01m 119.09m 122.48m 123.89m 139.48m 141.55m 143.93m 160.15m 171.39m 180.9m 181.31m 182.86m 0m 0m
OCF Operating Cash Flow
$-23.28M $-25.47M $-35.18M $39.83M $-62.63M $-61.76M $6.81M $-124.03M $10.88M $-1.11M $-60.00M $-133.20M $-96.97M $-118.90M $-203.54M $-163.74M $856.57M $-499.01M $-453.75M $0.00M $0.00M
FCF Free Cash Flow
$-29.00M $-26.87M $-36.86M $35.55M $-67.51M $-66.35M $-66.25M $-135.28M $1.00M $-23.26M $-77.18M $-146.60M $-124.81M $-147.62M $-224.76M $-234.49M $774.16M $-551.34M $-531.09M $0.00M $0.00M
FCFS Free Cash Flow Per Share
$-0.73 $-0.64 $-0.76 $0.58 $-0.86 $-0.73 $0.03 $-1.20 $0.00 $-0.19 $-0.63 $-1.13 $-0.89 $-1.03 $-1.43 $-1.42 $4.43 $-3.03 $-2.88 $0.00 $0.00